Cargando…
Management of acute COPD exacerbations in Australia: do we follow the guidelines?
OBJECTIVE: We aimed to assess adherence to the Australian national guideline (COPD-X) against audited practice, and to document the outcomes of patients hospitalised with an acute exacerbation of chronic obstructive pulmonary disease (COPD) at discharge and 28 days after. METHODS: A prospective clin...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167211/ https://www.ncbi.nlm.nih.gov/pubmed/32337215 http://dx.doi.org/10.1183/23120541.00270-2019 |
_version_ | 1783523536671866880 |
---|---|
author | Cousins, Joyce L. Wood-Baker, Richard Wark, Peter A.B. Yang, Ian A. Gibson, Peter G. Hutchinson, Anastasia Sajkov, Dimitar Hiles, Sarah A. Samuel, Sameh McDonald, Vanessa M. |
author_facet | Cousins, Joyce L. Wood-Baker, Richard Wark, Peter A.B. Yang, Ian A. Gibson, Peter G. Hutchinson, Anastasia Sajkov, Dimitar Hiles, Sarah A. Samuel, Sameh McDonald, Vanessa M. |
author_sort | Cousins, Joyce L. |
collection | PubMed |
description | OBJECTIVE: We aimed to assess adherence to the Australian national guideline (COPD-X) against audited practice, and to document the outcomes of patients hospitalised with an acute exacerbation of chronic obstructive pulmonary disease (COPD) at discharge and 28 days after. METHODS: A prospective clinical audit of COPD hospital admission from five tertiary care hospitals in five states of Australia was conducted. Post-discharge follow-up was conducted via telephone to assess for readmission and health status. RESULTS: There were 207 admissions for acute exacerbation (171 patients; mean 70.2 years old; 50.3% males). Readmission rates at 28 days were 25.4%, with one (0.6%) death during admission and eight (6.1%) post-discharge within 28 days. Concordance to the COPD-X guidance was variable; 22.7% performed spirometry, 81.1% had blood gases collected when forced expiratory volume in 1 s was <1 L, 99.5% had chest radiography performed, 95.1% were prescribed systemic corticosteroids and 95% were prescribed antibiotic therapy. There were 89.1% given oxygen therapy and 92.6% when arterial oxygen tension was <80 mmHg; 65.6% were given ventilatory assistance when pH was <7.35. Only 32.4% were referred to pulmonary rehabilitation but 76.8% had general practitioner follow-up arranged. CONCLUSION: When compared against clinical practice guidelines, we found important gaps in management of patients admitted with COPD throughout tertiary care centres in Australia. Strategies to improve guideline uptake are needed to optimise care. |
format | Online Article Text |
id | pubmed-7167211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-71672112020-04-24 Management of acute COPD exacerbations in Australia: do we follow the guidelines? Cousins, Joyce L. Wood-Baker, Richard Wark, Peter A.B. Yang, Ian A. Gibson, Peter G. Hutchinson, Anastasia Sajkov, Dimitar Hiles, Sarah A. Samuel, Sameh McDonald, Vanessa M. ERJ Open Res Original Articles OBJECTIVE: We aimed to assess adherence to the Australian national guideline (COPD-X) against audited practice, and to document the outcomes of patients hospitalised with an acute exacerbation of chronic obstructive pulmonary disease (COPD) at discharge and 28 days after. METHODS: A prospective clinical audit of COPD hospital admission from five tertiary care hospitals in five states of Australia was conducted. Post-discharge follow-up was conducted via telephone to assess for readmission and health status. RESULTS: There were 207 admissions for acute exacerbation (171 patients; mean 70.2 years old; 50.3% males). Readmission rates at 28 days were 25.4%, with one (0.6%) death during admission and eight (6.1%) post-discharge within 28 days. Concordance to the COPD-X guidance was variable; 22.7% performed spirometry, 81.1% had blood gases collected when forced expiratory volume in 1 s was <1 L, 99.5% had chest radiography performed, 95.1% were prescribed systemic corticosteroids and 95% were prescribed antibiotic therapy. There were 89.1% given oxygen therapy and 92.6% when arterial oxygen tension was <80 mmHg; 65.6% were given ventilatory assistance when pH was <7.35. Only 32.4% were referred to pulmonary rehabilitation but 76.8% had general practitioner follow-up arranged. CONCLUSION: When compared against clinical practice guidelines, we found important gaps in management of patients admitted with COPD throughout tertiary care centres in Australia. Strategies to improve guideline uptake are needed to optimise care. European Respiratory Society 2020-04-19 /pmc/articles/PMC7167211/ /pubmed/32337215 http://dx.doi.org/10.1183/23120541.00270-2019 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
spellingShingle | Original Articles Cousins, Joyce L. Wood-Baker, Richard Wark, Peter A.B. Yang, Ian A. Gibson, Peter G. Hutchinson, Anastasia Sajkov, Dimitar Hiles, Sarah A. Samuel, Sameh McDonald, Vanessa M. Management of acute COPD exacerbations in Australia: do we follow the guidelines? |
title | Management of acute COPD exacerbations in Australia: do we follow the guidelines? |
title_full | Management of acute COPD exacerbations in Australia: do we follow the guidelines? |
title_fullStr | Management of acute COPD exacerbations in Australia: do we follow the guidelines? |
title_full_unstemmed | Management of acute COPD exacerbations in Australia: do we follow the guidelines? |
title_short | Management of acute COPD exacerbations in Australia: do we follow the guidelines? |
title_sort | management of acute copd exacerbations in australia: do we follow the guidelines? |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167211/ https://www.ncbi.nlm.nih.gov/pubmed/32337215 http://dx.doi.org/10.1183/23120541.00270-2019 |
work_keys_str_mv | AT cousinsjoycel managementofacutecopdexacerbationsinaustraliadowefollowtheguidelines AT woodbakerrichard managementofacutecopdexacerbationsinaustraliadowefollowtheguidelines AT warkpeterab managementofacutecopdexacerbationsinaustraliadowefollowtheguidelines AT yangiana managementofacutecopdexacerbationsinaustraliadowefollowtheguidelines AT gibsonpeterg managementofacutecopdexacerbationsinaustraliadowefollowtheguidelines AT hutchinsonanastasia managementofacutecopdexacerbationsinaustraliadowefollowtheguidelines AT sajkovdimitar managementofacutecopdexacerbationsinaustraliadowefollowtheguidelines AT hilessaraha managementofacutecopdexacerbationsinaustraliadowefollowtheguidelines AT samuelsameh managementofacutecopdexacerbationsinaustraliadowefollowtheguidelines AT mcdonaldvanessam managementofacutecopdexacerbationsinaustraliadowefollowtheguidelines |